VLTR-621

N/A

Report date: 2023/04/23 16:11:35

Base Information

Drug NameVLTR-621
Drug Alias NameVLTR-621
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor necrosis factor receptor inhibitors
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValitor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A